cytarabine has been researched along with squalene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benoy, CJ; Elson, LA; Jones, M; Schneider, R | 1 |
| Couvreur, P; Desmaële, D; Dubernet, C; Marque, PE; Mouelhi, SL; Reddy, LH | 1 |
| Castelli, F; Ceruti, M; Giuffrida, MC; Ottimo, S; Rocco, F; Sarpietro, MG | 1 |
| Ceruti, M; Cosco, D; Fresta, M; Paolino, D; Rocco, F; Vono, M | 1 |
4 other study(ies) available for cytarabine and squalene
| Article | Year |
|---|---|
Enhancement of the cancer chemotherapeutic effect of the cell cycle phase specific agents methotrexate and cytosine arabinoside when given as a water-oil-water emulsion.
Topics: Animals; Carcinoma 256, Walker; Cytarabine; Emulsions; Lymphoma; Methotrexate; Mice; Neoplasms, Experimental; Squalene; Time Factors; Water | 1974 |
Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.
Topics: Animals; Antineoplastic Agents; Cytarabine; Deoxycytidine; Drug Evaluation, Preclinical; Gemcitabine; Leukemia; Mice; Mice, Inbred DBA; Nanomedicine; Nanostructures; Squalene; Treatment Outcome | 2008 |
Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Cytarabine; Dimyristoylphosphatidylcholine; Lipid Bilayers; Liposomes; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Prodrugs; Squalene | 2011 |
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytarabine; Humans; Leukemia; Liver; Mice; Nanomedicine; Nanoparticles; Particle Size; Spleen; Squalene; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays | 2012 |